Central Drugs Standard Control Organisation

New Delhi: India will require funding of Rs 80,000 crore for distribution of the COVID vaccine for the next one year, said Serum Institute of India, which has partnered with AstraZeneca to manufacture the Oxford-AstraZeneca vaccine, ZeeNews…

New Delhi: There is a recommendation to grant permission to the Serum Institute of India (SII) to conduct the second and third phases of human clinical trials of the Oxford vaccine candidate, NDTV reported. The recommendations of the…